Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Corvus Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 92 | 103 | +11 |
| Shares | 41.8M | 42.4M | +660.7K (+1.6%) |
| Value | $167.1M | $312.7M | +$145.5M (+87.1%) |
New holders (23)
Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| StemPoint Capital LP | 96,439 | $710.8K | 0.14% |
| NEOS Investment Management LLC | 59,202 | $436.3K | 0.00% |
| Tema ETFs LLC | 59,202 | $436.3K | 0.04% |
| Citadel Advisors LLC | 42,766 | $315.2K | 0.00% |
| Jain Global LLC | 27,618 | $203.5K | 0.00% |
| Axq Capital, LP | 27,051 | $199.4K | 0.08% |
| D. E. Shaw & Co., Inc. | 25,575 | $188.5K | 0.00% |
| Balyasny Asset Management LLC | 25,572 | $188.5K | 0.00% |
| Creative Planning | 25,299 | $186.5K | 0.00% |
| Palumbo Wealth Management LLC | 23,614 | $174.0K | 0.06% |
| Brevan Howard Capital Management LP | 15,300 | $112.8K | 0.00% |
| Shelton Wealth Management, LLC | 13,742 | $101.3K | 0.05% |
| Trexquant Investment LP | 12,226 | $90.1K | 0.00% |
| Russell Investments Group, Ltd. | 6,661 | $49.1K | 0.00% |
| Quarry LP | 3,653 | $26.9K | 0.01% |
| The PNC Financial Services Group, Inc. | 299 | $2.20K | 0.00% |
| UMA Financial Services, Inc. | 177 | $1.30K | 0.00% |
| SRS Capital Advisors, Inc. | 146 | $1.08K | 0.00% |
| GAMMA Investing LLC | 94 | $693 | 0.00% |
| Signaturefd, LLC | 76 | $560 | 0.00% |
| Wall Street Access Asset Management, LLC | 75 | $553 | 0.00% |
| Aquatic Capital Management LLC | 55 | $405 | 0.00% |
| CWM, LLC | 57 | $0 | 0.00% |
Sold out (12)
Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Marshall Wace, LLP | 201,651 | $806.6K |
| Renaissance Technologies LLC | 165,188 | $660.8K |
| Squarepoint Ops LLC | 138,462 | $553.8K |
| BML Capital Management, LLC | 118,766 | $475.1K |
| Susquehanna International Group, LLP | 67,816 | $271.3K |
| Qube Research & Technologies Ltd | 43,969 | $175.9K |
| Bayesian Capital Management, LP | 17,500 | $70.0K |
| Voya Investment Management LLC | 14,774 | $59.1K |
| Sender Co & Partners, Inc. | 12,995 | $52.0K |
| Caitong International Asset Management Co., Ltd | 2,032 | $8.13K |
| FNY Investment Advisers, LLC | 2,005 | $8.00K |
| Comerica Bank | 365 | $1.46K |